EP Patent

EP2434886B1 — Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same

Assigned to Cydex Pharmaceuticals Inc · Expires 2019-10-16 · 7y expired

What this patent protects

Patent listed against melphalan-hydrochloride.

Drugs covered by this patent

melphalan-hydrochloride (MELPHALAN HYDROCHLORIDE)

Patent Metadata

Patent number: EP2434886B1
Jurisdiction: EP
Classification: —
Expires: 2019-10-16
Drug substance claim: No
Drug product claim: No
Assignee: Cydex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.